Militia Capital Partners’s Transmedics TMDX Stock Holding History

Militia Capital Partners’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$1.46M	Sell	12,000 -1,000	-8%	-$125K	0.34%	75
2025 Q3	$1.46M	Buy	13,000 +3,000	+30%	+$351K	0.36%	66
2025 Q2	$1.34M	Buy	+10,000	New	+$1.1M	0.31%	62

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Militia Capital Partners's TMDX Position: Q4 2025 in Review

Militia Capital Partners reduced its Transmedics (TMDX) stake by 7.7% in Q4 2025, selling an estimated $125K and leaving 12,000 shares worth $1.46M. The position accounts for 0.34% of the portfolio, ranked #75.

Militia Capital Partners first reported a position in TMDX in Q2 2025 and has held it in 3 quarters since. 429 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

Militia Capital Partners held 12,000 shares of Transmedics worth $1.46M as of Q4 2025.
Militia Capital Partners sold 1,000 Transmedics shares in Q4 2025, an estimated $125K.
Transmedics made up 0.34% of Militia Capital Partners's portfolio in Q4 2025, its #75 holding.
Militia Capital Partners first reported a position in Transmedics in Q2 2025 and has held it in 3 quarters since.
429 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on Militia Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.